{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-134376","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.182142+00:00","generated_at":"2026-06-28T13:34:35.671027+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Medifast Q3 revenue jumps 52% to $413M; EPS $3.56; coaches up 45%","bullets":["Revenue increased 52.3% to $413.4M; net income $42.0M, diluted EPS $3.56 (up 22.3%).","Active earning OPTA VIA coaches rose 44.9% to 61,000; revenue per coach $6,773 (up 7%).","Gross profit margin 74.3% (vs 75.2% last year); SG&A as % of revenue rose to 60.9% from 58.7%.","Full-year 2021 guidance: revenue $1.51B-$1.53B, EPS $13.27-$13.96.","Cash and investments $159.9M; declared $1.42/share dividend payable Nov 8; $26.3M share repurchases in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-134376","json":"https://secwatch.observer/filing/0001104659-21-134376.json","markdown":"https://secwatch.observer/filing/0001104659-21-134376.md","text":"https://secwatch.observer/filing/0001104659-21-134376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000110465921134376/0001104659-21-134376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000110465921134376/tm2131984d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:34:35.671027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}